Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus.

Clinica chimica acta; international journal of clinical chemistry - 30 Jan 2011

Chang Horng-Rong, Yang Shun-Fa, Tsai Jen-Pi, Hsieh Ming-Chia, Wu Sheng-Wen, Tsai Hui-Ching, Hung Tung-Wei, Huang Jun-Huang, Lian Jong-Da

Abstract excerpt

OBJECTIVE: Plasminogen activator inhibitor 1 (PAI-1) is thought to play a role in the pathogenesis of obesity and insulin resistance. A connection between gestational diabetes mellitus and the functional -675 PAI-1 genotype has been reported. Therefore, we examined the role of the PAI-1 gene polymorphism in kidney transplant recipients. METHODS: A total of 376 kidney transplant recipients were prospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Kidney Transplantation

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Postoperative Complications

Share to Regression Analysis

Source

Identifiers

PMID: 21070757
DOI: 10.1016/j.cca.2010.10.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus.PMID 21070757Read ↗

Gene polymorphisms are associated with posttransplantation diabetes mellitus among Taiwanese renal transplant recipients.Semantic proximity Read ↗

The association between PAI-1 -675 4G/5G polymorphism and type 2 diabetes mellitus.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.Semantic proximity Read ↗

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.Semantic proximity Read ↗

PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.Semantic proximity Read ↗

Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.Semantic proximity Read ↗

Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications.Semantic proximity Read ↗

Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.Semantic proximity Read ↗

PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population.Semantic proximity Read ↗

Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism.Semantic proximity Read ↗

Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.